Company research / PBSV

Pharma-Bio Serv, Inc. (PBSV)

CIK 0001304161 · OTC · Services-Management Consulting Services

  • Sector Services
  • Fiscal year ends Oct 31

For the year ended 2025-10-31, Pharma-Bio Serv, Inc. reported revenue of $9.00M. Revenue fell 5.3% from the prior annual period. Over the twelve months to 2026-07-31, revenue was $9.48M.

Key ratios (year ended 2025-10-31)

32.3%
Gross margin
-7.1%
Operating margin
-1.1%
Net margin
-0.8%
Return on year-end equity
-5.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-31
2025-10-312024-10-312023-10-312022-10-312021-10-312020-10-312019-10-312018-10-312017-10-312016-10-31
Revenue$9.48M$9.00M$9.51M$16.98M$19.40M$20.12M$21.56M$19.51M$17.80M$13.30Mn/a
Cost of Revenue$6.42M$6.09M$6.99M$11.91M$14.52M$14.76M$14.90M$13.33M$12.11M$9.46Mn/a
Gross Profit$3.07M$2.91M$2.52M$5.07M$4.88M$5.36M$6.67M$6.18M$5.69M$3.84M$5.78M
Operating Income-$154.9K-$637.7K-$1.29M$1.12M$1.17M-$3.85M$2.23M$1.70M-$1.26M-$777.8K-$91.8K
Depreciation & Amortization$57.9K$59.9K$23.3K$48.1K$51.1K$72.7K$86.3K$99.1K$74.6K$107.7K$312.6K
EBITDA-$97.0K-$577.8K-$1.26M$1.17M$1.23M-$3.78M$2.31M$1.80M-$1.19M-$670.1K$220.8K
Net Income$251.5K-$100.5K-$777.6K$1.31M$1.01M-$2.09M$2.05M$2.09M$1.28M-$1.41M-$256.6K
EPS (Diluted)n/a$0.00-$0.03$0.057n/an/an/an/an/a-$0.06-$0.01
Total Assets$11.44M$13.65M$16.29M$19.90M$20.65M$23.92M$29.92M$26.63M$25.38M$22.35M$24.00M
Total Liabilities$994.7K$1.74M$2.58M$3.78M$4.09M$5.01M$7.20M$6.03M$5.11M$1.60M$2.19M
Shareholders' Equity$10.44M$11.91M$13.72M$16.13M$16.56M$18.91M$22.72M$20.61M$20.26M$20.75M$21.81M
Cash & Equivalentsn/an/an/an/a$14.46M$17.47M$17.14M$15.49M$16.03M$11.59M$13.77M
Operating Cash Flow-$414.9K-$214.9K-$566.7K$1.89M$592.5K$804.8K$1.51M-$2.21M$3.72M-$922.7K$709.7K
Capital Expenditures$6.5K$6.6K$159.7K$7.3K$19.3K$10.8K$55.7K$57.4K$122.0K$57.0K$1.81M
Free Cash Flow-$421.4K-$221.5K-$726.4K$1.88M$573.2K$794.0K$1.46M-$2.27M$3.60M-$979.6K-$1.10M
Share Repurchases$11.6K$31.4K$11.3K$34.3K$82.0K$26.0K$1.7K$87.9K$56.5K$15.4K$45.9K
Dividends Paid$1.72M$1.72M$1.72M$1.72M$3.45M$1.73M$1.73M$0n/an/an/a
Shares Outstanding22.90M22.91M22.96M22.96M22.94M23.00M23.00M23.00M23.06M23.09M23.01M
Dividends Per Sharen/an/an/an/an/an/an/a$0.075n/an/an/a
Weighted Average Diluted Sharesn/a22.96M22.97M23.00M23.03M23.16M23.04M23.11M23.10M23.10M23.19M
EPS (Basic)n/an/an/an/an/an/an/an/an/a-$0.06-$0.01